Protecting patients, staff, and healthcare resources with early pathogen detection.
Healthcare providers face mounting pressure to deliver high-quality care while containing costs and protecting both patients and staff. Pathogen transmission in hospitals, nursing homes, and assisted living facilities not only worsens patient outcomes but also drives preventable costs through extended stays, higher morbidity, and staff exposures. Varro Life Sciences provides real-time detection solutions that allow facilities to intervene earlier, isolate effectively, and protect vulnerable populations.
Hospital Infection Control
Varro’s real-time pathogen identification enables hospitals to rapidly implement isolation protocols and targeted treatments. By shortening diagnostic times, providers can prevent healthcare-associated infections (HAIs), reduce morbidity, and avoid extended inpatient stays. Faster, accurate results protect staff, preserve critical resources, and improve patient safety.
Long-term and Congregate Care
Nursing homes and assisted living facilities house populations at highest risk of severe illness from respiratory and infectious diseases. With Varro’s rapid detection devices, administrators and clinicians can identify pathogens early, prevent devastating outbreaks, and intervene before infections spread widely through congregate living environments.
Resource Efficiency and Cost Savings
Accurate pathogen testing allows healthcare systems to allocate staff, equipment, and treatments more effectively. By distinguishing between pathogens quickly, Varro’s portfolio reduces unnecessary use of antibiotics, streamlines triage decisions, and lowers overall costs while improving patient outcomes.
Safeguarding Healthcare Capacity and Continuity
Healthcare-associated infections are a persistent challenge, affecting an estimated 1 in 31 hospital patients on any given day in the United States.¹ These infections increase morbidity, extend hospital stays, and contribute to nearly 100,000 deaths annually.² In long-term care facilities, outbreaks of respiratory viruses such as influenza and COVID-19 have been particularly devastating, with mortality rates far higher among elderly residents.³ The financial toll is significant: HAIs alone cost the U.S. healthcare system an estimated $28–45 billion each year.⁴ Varro’s rapid detection technology addresses these burdens by enabling faster isolation, more efficient resource allocation, and stronger protection for staff and patients.
The Varro Solution
Varro’s air bio-detector provides continuous surveillance in high-risk hospital areas such as emergency departments, ICUs, and waiting rooms. Breath-based devices extend testing into triage settings, long-term care, and outpatient facilities.
Measurable Outcomes:
- Reduced diagnostic and triage time
- Lower rates of healthcare-associated infections
- Optimized allocation of staff and treatment resources
- Improved outcomes in vulnerable populations
Protect patients, staff, and healthcare resources with early pathogen detection. Contact Varro Life Sciences to explore deployment across hospitals, nursing homes, and long-term care facilities.
- Centers for Disease Control and Prevention, “Healthcare-Associated Infections (HAIs),” last modified 2023, https://www.cdc.gov/hai/data/portal/index.html.
- Centers for Disease Control and Prevention, “HAI Data and Statistics,” last modified 2023, https://www.cdc.gov/hai/data/index.html.
- Centers for Disease Control and Prevention, “COVID-19 Nursing Home Data,” updated 2023, https://data.cms.gov/covid-19/covid-19-nursing-home-data.
- U.S. Department of Health and Human Services, “The Cost of Healthcare-Associated Infections in the U.S.,” Agency for Healthcare Research and Quality, 2020, https://www.ahrq.gov/hai/pfp/hai-cost.html.